Issue 12, 2012

Synthesis and binding affinities for sst receptors of cyclic peptoid SRIF-mimetics

Abstract

Mimicking the tetradecapeptide somatostatin through the design of novel non-peptide small molecules is needed for developing analogues with selective or universal affinity for human somatostatin receptors (hsst1–5) and improved pharmacological properties. We report the synthesis and evaluation of the binding potential of the first all-peptoid SRIF (somatotropin release-inhibiting factor) analogues. Cyclic β and mixed α/β tetra- or pentapeptoids were efficiently obtained by macrocyclisation of the corresponding linear peptoids. In vitro competition binding experiments using [125I]-somatostatin were performed on this first generation of peptoids mimicking the SRIF pharmacophore (Phe7-(D)Trp8-Lys9-Thr10). The selectivity profiles of cyclic compounds 1 to 4 were similar with higher affinity for the sst3, sst5 and sst4 receptors and lower potency on sst1 and sst2 subtypes.

Graphical abstract: Synthesis and binding affinities for sst receptors of cyclic peptoid SRIF-mimetics

Supplementary files

Article information

Article type
Concise Article
Submitted
06 Sep 2012
Accepted
09 Oct 2012
First published
09 Oct 2012

Med. Chem. Commun., 2012,3, 1531-1535

Synthesis and binding affinities for sst receptors of cyclic peptoid SRIF-mimetics

C. Caumes, T. Hjelmgaard, O. Roy, M. Reynaud, D. Servent, C. Taillefumier and S. Faure, Med. Chem. Commun., 2012, 3, 1531 DOI: 10.1039/C2MD20265D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements